29 October 2019 15:45 - 16:15
Session IV
The importance of cholesterol synthesis and absorption markers determination in healthy subjects and patients with ischemic heart disease

Tamara Gojkovic was born in 1985 in Pec, Serbia. She has graduated at Faculty of Pharmacy, University of Belgrade in 2010. During 2010, within Student Exchange Program, she did professional training in GlaxoSmithKline Company in Cairo, Egypt. She finished specialist academic studies in Biochemical diagnostics (2017) mentored by Professor Vesna Spasojevic-Kalimanovska and defended doctoral thesis entitled “The importance of cholesterol synthesis and absorption markers determination in healthy subjects and patients with ischemic heart disease” in 2018 at Faculty of Pharmacy, University of Belgrade mentored by Professor Zorana Jelic-Ivanovic.

Since 2011 she is employed as a collaborator on a project entitled "Interactive role of dyslipidemia, oxidative stress, and inflammation in atherosclerosis and other diseases: genetic and biochemical markers", funded by the Ministry of Education, Science and Technological Development of Republic of Serbia. She has worked as teaching assistant at Department of Medical Biochemistry, Faculty of Pharmacy from July 2016.

She participated in four international projects. From 2010 to 2014, associated in the international project within the COST program (European Cooperation in Science and Technology); Scientific Domain: Biomedicine and Molecular Biosciences; Action: “HDL: From Understanding to Clinical Biological Exploitation” (BM0904). From 2012 to 2014 participated of an international project within the framework of bilateral cooperation between the Republic of Serbia and the Republic of Slovenia “Diagnostic value of new biomarkers for the early detection of atherosclerosis in patients with thermal stage renal disease”, as well as the international project of bilateral cooperation between the Republic of Serbia and the Republic Croatia "Novel diagnostic and therapeutic approaches to complex genetic disorders” (2011-2014). Since 2017, she is a collaborator on an international project within the COST program “CliniMARK: 'good biomarker practice' to increase the number of clinically validated biomarkers (CA16113)”.

As an author or co-author Tamara Gojkovic published a total of 19 scientific papers and 43 presentations on international and national scientific meetings. Also, she acts as a reviewer for several international scientific journals. She has received scholarships to participate in the Congress of the European Atherosclerosis Society 2016, 2017 and 2018 (84th EAS Congress, Innsbruck, Austria; 85th EAS Congress, Prague, Czech Republic; 86th EAS Congress, Lisbon, Portugal), as well as scholarships for participation in summer schools in Portoroz in 2014 (International CEEPUS Summer school 2014: “Novel diagnostic and therapeutic approaches to complex genetic disorders”) and in 2015 (International CEEPUS Summer school 2015: “Complex Diseases – Hematological Diseases, Hormonal Dysfunctions, Neurodegenerative Diseases). For the purpose of professional development, she has received two-month student mobility grant on University of Zagreb Faculty of Pharmacy and Biochemistry (CEEPUS project 2013 Zagreb, Croatia). She has received scholarships for participation in summer school „Bioinformatics for Quantitative Genomics – Summer Training School“ in Madrid, Spain in 2018 (COST Action BM1406).

The research interest of Tamara Gojkovic is mainly focused on analysis of cholesterol synthesis and absorption markers and lipoproteins metabolism, as well as disturbances of cholesterol homeostasis in various pathological conditions associated with development of atherosclerosis. 

She is a member of Society of Medical Biochemists of Serbia, Serbian Biochemical Society, Serbian Society for Mitochondrial and Free-Radical Physiology and European Atherosclerosis Society.

Congress Venue

Papillon Zeugma Convention Centre, Belek Antalya - TURKEY

October 27-31, 2019